newsfilter
← Latest News
GlobeNewswire·

Zynerba Pharmaceuticals Presents Data on Zygel™ at the 55th Gatlinburg Conference

Zygel continued to be well-tolerated with long-term administration and maintained clinically meaningful improvements in children and adolescents with Fragile X syndrome Zygel achieved statistically significant and